As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
On Wednesday, Evergy's Director, C. John Wilder, made a $2.51M purchase of EVRG, buying 39,872 shares at a cost of $62.91 each. Investors can snag EVRG even cheaper than Wilder did, with shares changing hands as low as $61.34 in trading on Monday which is 2.5% under Wilder's purchase price. Evergy Inc is trading down about 0.9% on the day Monday. Before this latest buy, Wilder bought EVRG on 4 other occasions during the past twelve months, for a total cost of $121.94M at an average of $50.62 per share.
And at ImmunityBio, there was insider buying on Friday, by CEO & President Richard Adcock who bought 1,930 shares at a cost of $8.81 each, for a total investment of $16,995. ImmunityBio is trading up about 10.2% on the day Monday. So far Adcock is in the green, up about 12.3% on their purchase based on today's trading high of $9.89.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.